Survey Finds Disconnect Between Number of Americans Willing to Donate Organs and Number Currently Registered as Donors

 Survey Finds Disconnect Between Number of Americans Willing to Donate Organs
                  and Number Currently Registered as Donors

Findings are encouraging, however, as majority of respondents are generally
knowledgeable about organ donation

PR Newswire

NORTHBROOK, Ill., April 15, 2013

NORTHBROOK, Ill., April 15, 2013 /PRNewswire/ -- Astellas Pharma US, Inc.
("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo:
4503), today announced results of a national survey which found that while 60
percent of respondents were familiar with their state organ donor registries
and 57 percent would be willing to have their organs donated after they pass
away, only 43 percent were actually registered as organ donors. Forty-eight
percent indicated that they don't know how to register.

The 2013 "Save a Life Survey" was designed to determine public understanding
of transplantation and uncover common misperceptions related to organ
donation. Although 28 percent of respondents indicated no reason would stop
them from registering as an organ donor, the top reason cited for not
registering was the respondents' belief that they were not healthy enough (24
percent). In encouraging findings, respondents appeared to be generally
knowledgeable about organ donation, as the majority disagreed with myths
sometimes associated with donation: 73 percent disagreed with the statement
that religion prohibited organ donation, and 55 percent disagreed with the
statement that having an open casket funeral would be difficult should they
donate their organs.

"We are very encouraged by the number of Americans who view organ donation
positively and are willing to donate," said David Fleming, President and CEO,
Donate Life America. "However, knowing that there are more than 115,000 people
currently awaiting a transplant, we are committed to continuing our work to
educate all Americans on the importance of registering in their state,
ensuring they know how to register and encouraging them to discuss their
wishes to become an organ donor with their families."

Other survey findings include:

  oMany would be living organ donors: Nearly half (49 percent) indicated they
    would be willing to be a living donor to a friend or family member in need
    of a transplant.
  oRespondents are well aware of the vast need for donors: Eighty percent of
    respondents agree that the number of people awaiting transplants is higher
    than the number of organs and tissue actually available.
  oKnowing someone awaiting a transplant is a strong motivator for deciding
    to register: Respondents indicate that hearing about organ donation from
    someone currently waiting for a transplant or from the family of a person
    who passed away while waiting for a transplant would have the most impact
    on their likelihood to register to become an organ donor. Hearing about
    organ donation from faith leaders and teachers would have the least impact
    on their decision.

"As a leader in transplantation and immunology for the past two decades,
Astellas is committed to furthering understanding of organ donation and
transplantation in the U.S.," said Richard Miller, Vice President, Strategic
Relations, Astellas Pharma US, Inc. "Our goal in issuing these survey findings
in celebration of Organ Donation Awareness Month this April is to help
increase awareness of the importance of organ donation and encourage more
people to take the easy steps to register as organ donors."

For more information on Organ Donation Awareness Month and to learn how to
register as a donor, visit www.donatelife.net.

About the Survey

The study was conducted through Directions Research, Inc., on behalf of
Astellas, using online self-administered surveys with an average length of
nine minutes. Surveys were collected over five days, from Thursday, Feb. 28 to
Monday March 4, 2013. A total of 1,010 completed surveys were collected.
Respondents were required to be at least 18 years of age to complete the
survey. Age and gender quotas were set in order for the survey sample to more
closely mirror the overall population. Respondents were recruited from
consumer panels, pre-recruited groups of people that are both interested in
and willing to participate in marketing research.

About Astellas

Astellas is a recognized leader in transplantation and has been committed to
the field of immunology for more than 20 years. Dedicated to supporting the
advancement of care for patients, Astellas continues to build upon its legacy
and leadership in transplantation by investing in ongoing clinical research
and new product development.

Astellas Pharma US, Inc., located in Northbrook, Illinois, is a US affiliate
of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company
dedicated to improving the health of people around the world through the
provision of innovative and reliable pharmaceutical products. The organization
is committed to becoming a global category leader in focused areas by
combining outstanding R&D and marketing capabilities. For more information
about Astellas Pharma US, Inc., please visit our website at www.Astellas.us.



SOURCE Astellas Pharma US, Inc.

Website: http://www.Astellas.us
Contact: Jenny M. Kite, Astellas, (847) 682-4530 cell,
Jenny.Kite@Astellas.com; Anne Maselli, Edelman, (312) 297-6979 office, (708)
790-3135 cell, Anne.Maselli@Edelman.com
 
Press spacebar to pause and continue. Press esc to stop.